Is Vaishali Pharma Ltd (VAISHALI) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vaishali Pharma Ltd is a average quality company .

Is Vaishali Pharma Ltd (VAISHALI) undervalued or overvalued?

The key valuation ratios of Vaishali Pharma Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Vaishali Pharma Ltd (VAISHALI) share price return in the past 10 years?

Data is not available for this company

Is Vaishali Pharma Ltd (VAISHALI) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Vaishali Pharma Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Vaishali Pharma Ltd (VAISHALI)?

Company share prices are keep on changing according to the market conditions. The current trading price of Vaishali Pharma Ltd (VAISHALI) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the market cap of Vaishali Pharma Ltd (VAISHALI)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 at 05:30, the market cap of Vaishali Pharma stood at Rs. 100.85 Cr.

What is the P/E ratio of Vaishali Pharma?

The latest standalone P/E ratio of Vaishali Pharma as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Vaishali Pharma Ltd (VAISHALI)?

The latest standalone P/B ratio of Vaishali Pharma Ltd (VAISHALI) as of 01-Jan-1970 is 1.47.

What is the 52-week high and low of Vaishali Pharma Ltd (VAISHALI)?

The 52-week high of Vaishali Pharma Ltd (VAISHALI) is Rs. 0.00 and the 52-week low is Rs. 0.00.

What is the TTM revenue of Vaishali Pharma Ltd (VAISHALI)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vaishali Pharma is Rs. 113.46 (Cr.).

Vaishali Pharma Ltd (VAISHALI) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Vaishali Pharma Ltd (VAISHALI)
Brand: Vaishali Pharma

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	12.8%	16.2%	12.8%	9.8%	6.9%	10.3%	18.9%	21.9%	5.8%	5%	-
Value Creation Index ⓘ	-0.1	0.2	-0.1	-0.3	-0.5	-0.3	0.4	0.6	-0.6	-0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	66.7	64	67.8	75.1	60.1	53.8	75.8	69.7	86.3	99	113
Sales YoY Gr.	-	-4.1%	5.9%	10.8%	-20%	-10.5%	41%	-8.1%	23.9%	14.8%	-
Adj EPS ⓘ	-0	0	0.1	0	-0.1	0.1	0.4	0.6	0.1	0.1	-0
YoY Gr.	-	NA	250%	-71.4%	-350%	NA	400%	68.6%	-89.8%	-16.7%	-
BVPS (₹) ⓘ	0.7	0.1	2	2	2	2.1	2.5	3.1	3.3	5	5.3
Adj Net Profit ⓘ	-0.1	0.7	0.7	0.2	-0.6	0.8	3.7	6.2	0.6	0.6	-1
Cash Flow from Ops. ⓘ	4.6	0.5	-9.5	4.3	3.2	2	1.3	1.1	0.8	-18	-
Debt/CF from Ops. ⓘ	4.6	49.6	-1.9	4	5.2	8.7	15.8	12.7	15.6	-0.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.5%	10.5%	9.3%	14.8%
Adj EPS ⓘ	NA	NA	-47.7%	-16.7%
BVPSⓘ	25%	19.7%	25.8%	49.1%
Share Price	-	-28.7%	-62.5%	-35.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-1.5	19.8	5.6	1	-2.7	3.5	15.2	18.6	1.4	1.1	-0.8
Op. Profit Mgn % ⓘ	0.8	5.4	4.1	2.8	1.5	4.9	9.1	13.5	1.9	0.6	-1.5
Net Profit Mgn % ⓘ	-0.1	1.1	1	0.3	-1	1.4	4.9	8.9	0.7	0.6	-0.5
Debt to Equity ⓘ	6.6	5.8	0.9	0.8	0.8	0.8	0.8	0.4	0.4	0.2	-
Working Cap Days ⓘ	244	255	283	312	396	501	390	400	318	333	149
Cash Conv. Cycle ⓘ	104	107	122	115	137	152	122	168	135	98	89

Recent Performance Summary

Sales growth is good in last 4 quarters at 19.53%

Return on Equity is Poor

Sales growth has been subdued in last 3 years 9.31%

	Standalone	Consolidated
TTM EPS (₹)	-0	-
TTM Sales (₹ Cr.)	113	-
BVPS (₹) ⓘ	5.3	-
Reserves (₹ Cr.) ⓘ	43	-
P/BV ⓘ	1.47	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	101
Equity (₹ Cr.)	26.1
Face Value (₹)	2
Industry PE ⓘ	33.2

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-0.94	19.8	6.49	3.4	0.15	4.78	16.5	22.26	2.09	1.62
ROCE (%)	12.8	16.18	12.75	9.8	6.89	10.33	18.87	21.92	5.82	4.99
Asset Turnover Ratio	1.4	1.36	1.25	1.13	0.89	0.71	0.91	0.87	1.09	1.05
PAT to CFO Conversion(x)	N/A	0	-9	4	N/A	2	0.25	0.14	1	-18
Working Capital Days
Receivable Days	204.60	222.20	221	228.50	293	386.10	301.40	293.70	218	177.20
Inventory Days	18.30	12.90	8.10	6.90	5.70	5	2.90	9.60	7.30	9.60
Payable Days	123.10	130.10	115.10	124.70	172.10	253.80	198.10	154.80	91.70	99.10

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	67	64	68	75	60	54	76	70	86	99
Operating Expenses ⓘ +	66	60	65	73	59	51	69	60	85	98
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	62	56	60	69	51	46	64	55	74	86
Employee Cost	2	2	2	2	1	1	1	1	1	2
Other Costs ⓘ	3	3	3	2	7	4	4	4	9	11
Operating Profit ⓘ	1	3	3	2	1	3	7	9	2	1
Operating Profit Margin (%)	0.8%	5.4%	4.1%	2.8%	1.5%	4.9%	9.1%	13.5%	1.9%	0.6%
Other Income ⓘ +	3	1	2	2	2	2	2	2	2	3
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	3	3	3	3	3	3	2	2	2	2
Depreciation ⓘ	0	0	0	0	0	0	0	1	1	0
Profit Before Tax ⓘ	-0	1	1	1	0	1	6	9	1	1
Tax ⓘ	0	0	1	0	0	0	2	2	0	0
Profit After Tax	-0	1	1	1	0	1	4	7	1	1
PAT Margin (%)	-0.1%	1.1%	1.2%	1.0%	0.1%	2.0%	5.3%	9.5%	0.8%	0.8%
Adjusted EPS (₹)	-0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	3	4	21	21	21	22	26	33	36	65
Share Capital ⓘ	1	3	7	7	11	11	11	11	11	26
Reserves ⓘ	3	1	14	15	11	12	16	22	25	39
Debt +	20	21	18	16	16	16	20	13	11	8
Long Term Debt	4	3	3	5	4	4	3	5	4	4
Short Term Debt	15	18	15	11	12	12	17	7	8	4
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	25	15	22	25	24	41	28	18	19	27
Others Liabilities ⓘ	2	4	4	6	5	7	7	15	13	9
Total Liabilities ⓘ	49	45	64	69	66	86	81	79	80	110
Fixed Assets
Net Fixed Assets ⓘ +	1	1	1	1	1	1	1	2	2	2
Gross Block	3	2	2	2	3	3	3	4	4	5
Accumulated Depreciation	1	0	1	1	1	2	2	2	2	3
CWIP ⓘ	0	0	0	0	0	0	0	1	1	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	3	1	2	1	1	1	1	3	0	5
Trade Receivables	40	37	45	49	47	67	59	54	49	47
Cash Equivalents	1	0	0	0	0	0	1	1	2	2
Others Assets ⓘ	3	4	16	16	16	16	19	18	26	54
Total Assets ⓘ	49	45	64	69	66	86	81	79	80	110

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	5	0	-9	4	3	2	1	1	1	-18
PBT ⓘ	-0	1	1	1	0	1	6	9	1	1
Adjustment ⓘ	1	2	2	2	6	3	2	1	6	7
Changes in Working Capital ⓘ	4	-3	-12	2	-2	-3	-5	-7	-4	-26
Tax Paid ⓘ	-0	-0	-0	-0	-1	-0	-1	-2	-2	-0
Cash Flow From Investing Activity ⓘ +	3	1	1	-0	-0	-0	-1	0	1	-0
Capex	-0	-0	-0	-0	-0	-0	-1	-0	-0	-0
Net Investments	0	0	-0	0	0	0	0	0	0	0
Others ⓘ	3	1	1	0	0	0	0	1	1	0
Cash Flow From Financing Activity ⓘ +	-8	-1	8	-4	-3	-2	0	-2	-1	18
Net Proceeds from Shares ⓘ	0	0	16	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-4	2	-2	2	-1	1	-2	2	-1	1
Interest Paid ⓘ	-3	-3	-3	-3	-3	-3	-2	-2	-2	-1
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-1	-1	-3	-3	0	-0	5	-2	2	19
Net Cash Flow ⓘ	0	-0	0	0	0	0	1	-0	1	0

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Vaishali Pharma Ltd (VAISHALI) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating